Franklin Covey (FC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
19 Dec, 2025Executive summary
Q2 FY25 revenue was $59.6M (down 2.8% year-over-year), impacted by government contract cancellations, macroeconomic and geopolitical uncertainty, and lower North America and International sales; Education Division revenue grew 3% to $15.1M, partially offsetting declines.
Adjusted EBITDA for Q2 FY25 was $2.1M ($2.6M constant currency), down from $7.4M in Q2 FY24; net loss for Q2 FY25 was $(1.1)M, or $(0.08) per share, compared to net income of $0.9M in Q2 FY24.
Deferred subscription revenue increased 10% year-over-year to $94.4M, with 55% of All-Access Pass contracts for at least two years.
Liquidity remains strong with $40.4M in cash and a fully undrawn $62.5M credit facility at quarter-end.
Free cash flow for the first half was $7.8M, down from $24.7M year-over-year.
Financial highlights
First half FY25 consolidated revenue was $128.7M, nearly flat year-over-year; Q2 gross margin improved to 76.7%.
Operating expenses rose $6.1M in the first half, mainly due to $7.3M higher SG&A from new hires and compensation increases.
Adjusted EBITDA margin for Q2 FY25 was 3.5%, down from 12.1% in Q2 FY24.
Cash and cash equivalents at quarter-end were $40.4M.
Share count as of March 31, 2025, was 12,988k.
Outlook and guidance
FY25 revenue guidance lowered to $275M–$285M, midpoint 2.5% below FY24 and 5% below original guidance, reflecting $10M–$20M revenue impact and $7M–$10M EBITDA impact from government and international headwinds.
Adjusted EBITDA guidance for FY25 is $30M–$33M, down from prior guidance of $40M.
Management expects FY25 to be a one-year step back, with FY26 Adjusted EBITDA expected to rebound and resume growth; specific 2026 guidance to be provided in November.
Q3 guidance: revenue of $67M–$71M and adjusted EBITDA of $4M–$6.5M.
Latest events from Franklin Covey
- FY25 revenue and profit declined, but FY26 guidance anticipates margin recovery and growth.FC
Q4 202510 Mar 2026 - Q3 revenue, net income, and cash flow rose, with record fiscal 2024 results expected.FC
Q3 20243 Feb 2026 - Strong FY24 results and growth investments set stage for double-digit growth from FY26.FC
Q4 202416 Jan 2026 - Q1 FY25 revenue up 1% to $69.1M; Education led growth, net income fell on higher costs.FC
Q1 202510 Jan 2026 - Q1 revenue fell 7% to $64M, net loss was $3.3M, but FY2026 growth guidance was reaffirmed.FC
Q1 20269 Jan 2026 - Annual meeting to elect directors, approve pay, ratify auditors, and advance ESG priorities.FC
Proxy Filing18 Dec 2025 - Annual meeting covers director elections, pay, auditor, and incentive plan amendment.FC
Proxy Filing1 Dec 2025 - Amendment updates equity compensation plan details and voting instructions for the 2025 meeting.FC
Proxy Filing1 Dec 2025 - Clarification issued: abstentions and broker non-votes won't affect Proposal No. 4's outcome.FC
Proxy Filing1 Dec 2025